Healthesystems’ Chief Medical Officer comments on the U.S. House’s approval of marijuana decriminalization.
Healthesystems’ Chief Medical Officer comments on the U.S. House’s approval of marijuana decriminalization.
Healthesystems’ clinical leaders speak to mitigation strategies to reduce workplace injuries stemming from fatigue.
Healthesystems’ Chief Medical Officer explores trends impacting workers’ comp, including patient engagement, population health, and more.
Despite having little clinical impact, topical creams continue to be utilized widely in workers’ comp.
Dr. Robert Goldberg and Sandy Shtab talk with Risk & Insurance about changing attitudes and policies around medical marijuana, its potential role in reducing reliance on opioids, and what this can mean for payers, employers, patients and PBMs.
Healthesystems’ clinical leaders comment on the collective responsibility of healthcare entities, providers, and legislators to increase efforts that will help stem opioid overprescribing, misuse and overdose.
Healthesystems’ Chief Medical Officer spoke with WorkCompCentral regarding DEA plans to reduce opioid manufacturing.
Our Chief Medical Officer and VP of Clinical Services comment on matters such as the use of anticonvulsants to treat pain and opioid prescriptions for inpatients.
Our Chief Medical Officer and VP of Clinical Services comment on the clinical use of ecstasy and marijuana.
